Skip to main content

Table 5 Phenotype of patients according the presence of non-headache symptoms throughout all three phases of migraine

From: Tracking the evolution of non-headache symptoms through the migraine attack

 

Patients having at least one non-headache symptom throughout all three phases of migraine

Patients having at least one non-headache symptom in one or two phases of migraine

p value*

Non-headache symptoms in all phases vs non-headache symptoms in one or two phases of migraine

N° of subjects

122 (54%)

103 (46%)

Median age [IQ range] [years]

45 [34–51]

47 [34–57]

0.099

Women/Men

104 (85%) – 18 (15%)

70 (68%) – 33 (32%)

0.002

Median disease duration [IQ range]

30 [16–39]

30 [20–40]

0.914

Migraine with aura/Migraine without aura

30 (25%) – 92 (75%)

18 (17%) – 85 (83%)

0.253

Median monthly headache days [IQ range]

20 [9–30]

12 [7–23]

0.001

Median monthly migraine days [IQ range]

15 [8–20]

11 [6–17]

0.056

Episodic/Chronic migraine

40 (33%) - 82 (67%)

57 (55%) – 46 (45%)

0.001

Patients taking/not taking migraine prevention

47 (39%)/ 75 (61%)

34 (33%)/ 69 (67%)

0.4

Median of preventive treatments used

3 [1–5]

3 [0–5]

0.153

Migraine with medication overuse/ Migraine without medication overuse

70 (57%) – 52 (43%)

40 (39%) – 63 (61%)

0.004

Median of monthly tablets of acute treatments [IQ range]

16 [8–30]

12 [5–20]

0.015

Median MIDAS score [IQ range]

55 [20–103]

34 [17–69]

0.004

Median HIT-6 score [IQ range]

66 [63–69]

64 [61–67]

0.002

Median NRS score [IQ range]

8 [7–9]

8 [7–9]

0.156

Median ASC score [IQ range]

5 [2–8]

4 [1–7]

0.130

  1. *Independent t test or Mann-Whitney test for continuous variables and the Fisher exact test for categorical variables